Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Zelda Therapeutics Ltd (ZLDAF)

Zelda Therapeutics Ltd (ZLDAF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade ZLDAF with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.4704 +2.04%
on 04/03/24
0.4800 unch
on 04/04/24
-0.0508 (-9.57%)
since 03/04/24
3-Month
0.4704 +2.04%
on 04/03/24
0.6292 -23.71%
on 01/05/24
-0.1096 (-18.59%)
since 12/29/23
52-Week
0.4704 +2.04%
on 04/03/24
1.6500 -70.91%
on 06/01/23
-0.1704 (-26.20%)
since 03/30/23

Most Recent Stories

More News
Zelira Therapeutics Launches ZYRAYDIâ„¢ B2B Technology to Create Pharma-grade Cannabis Capsules & Tablets for Global Markets

/PRNewswire/ -- Zelira Therapeutics Ltd (ASX:ZLD, OTCQB:ZLDAF), a global leader in the research, development and commercialization of clinically validated...

ZLDAF : 0.4800 (+2.04%)
Zelira's Zenivolâ„¢, the World's First Clinically Validated Cannabinoid Medication for Insomnia, Achieves Regulatory Approval in Germany

/PRNewswire/ -- Zelira Therapeutics Ltd (ASX: ZLD, OTC-QB: ZLDAF), a global leader in the research, development and commercialization of clinically validated...

ZLDAF : 0.4800 (+2.04%)
Proactive news headlines including Volt Resources, Orthocell, Zelira Therapeutics and Tempus Resources

Sydney, June 21, 2021 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered the following companies:

OCC : 2.79 (-0.36%)
ZLDAF : 0.4800 (+2.04%)
TMRR : 0.1500 (-11.76%)
TMRFF : 0.0021 (-47.50%)
RPM : 107.43 (+0.49%)
Proactive news headlines including Shree Minerals, Emperor Energy, SUDA Pharmaceuticals and Zelira Therapeutics

Sydney, June 18, 2021 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered the following companies:

EMP : 21.83 (+0.55%)
ZLDAF : 0.4800 (+2.04%)
ARU : 25.20 (-0.32%)
ARAFF : 0.1350 (unch)
DNK : 2.37 (+0.72%)
DNK.LN : 20.000 (unch)
DNKLY : 0.2429 (+2.49%)
AXE : 97.85 (-0.02%)
ARRXF : 0.3200 (+25.49%)
PAR : 42.20 (-0.19%)
PBIGF : 0.1793 (+7.43%)
KIN : 9.25 (+0.11%)
Proactive news headlines including Element 25, Bellevue Gold, Zelira Therapeutics and St George Mining

Sydney, April 15, 2021 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered the following companies:

BELGF : 1.4700 (+28.95%)
ZLDAF : 0.4800 (+2.04%)
FYIRF : 0.1000 (+178.55%)
HLX : 10.58 (-1.49%)
MXC : 12.05 (-2.81%)
MXC.LN : 22.000 (unch)
MGCLF : 0.2600 (-7.14%)

Key Turning Points

3rd Resistance Point 0.4876
2nd Resistance Point 0.4838
1st Resistance Point 0.4819
Last Price 0.4800
1st Support Level 0.4762
2nd Support Level 0.4724
3rd Support Level 0.4705

See More

52-Week High 1.6500
Fibonacci 61.8% 1.1994
Fibonacci 50% 1.0602
Fibonacci 38.2% 0.9210
Last Price 0.4800
52-Week Low 0.4704

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar